- Featured News /Today, Novartis CEO Vas Narasimhan announced the company’s financial results for the third quarter of 2018.
- Featured News /
European Patient Innovation Summit publishes a position paper on Digital Health from a Patient Perspective with recommendations on digital health.
- Featured News /
On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.
- Featured News /
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
- Featured News /Novartis CEO Vas Narasimhan announced the company’s fourth quarter and 2018 full year results.
- Featured News /
Novartis announced the company’s financial results for the first quarter of 2019.
- Featured News /
From January 13-16 2020, Novartis attended the J.P Morgan Healthcare Conference in San Francisco.
- Featured News /
- Featured News /
Novartis announced the company’s financial results for the second quarter and first half of 2019.
- Featured News /
Novartis announces the company’s fourth quarter and 2019 full year financial results.
Pagination
- ‹ Previous page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- …
- 20
- › Next page